St. Jude Announces Global Launch of Its PSA Wand

St. Jude Medical has launched its first integrated pacing system analyzer (PSA) wand, which attaches to St. Jude Medical programmers and enables clinicians to conduct implantation testing and performance threshold testing, as well as programming and interrogation of pacemakers, implantable cardioverter-defibrillators (ICDs) and emerging indications devices without the need for separate analyzer hardware.

Designed to emulate St. Jude Medical implantable devices, the PSA Wand can accurately measure the heart's intrinsic P- and R-wave signals, evaluate thresholds, and provide lead system analysis. Because the PSA Wand can also program and interrogate devices, it can increase efficiency by functioning as an analyzer or telemetry wand.

Another advantage offered by the PSA Wand is that it adjusts the signal filter and pulse widths to match the type of device being implanted, including pacemakers and ICDs, saving time and promoting more accurate measurements.